Data from the ASCENT study of LIQ861 (YUTREPIA™) in PH-ILD patients highlights safety, tolerability, exploratory changes in six-minute walk ...

Biosciences, announced that its collaboration partner, PeriNess has entered into a Clinical Study Agreement to support an ...

Residents have complained their high quality of life has disintegrated because of the airport; two added to airport noise ...

Alzinova AB (publ) (ticker: ALZ) today announces that the final analysis of data from the Phase 1b clinical study with the vaccine candidate ALZ-101, which included patients with early Alzheimer's dis ...

SAVA and ALNY are in the spotlight this week following a study failure and label expansion of lead drug, respectively.

UKAEA awards £3.5m to develop highly specialised sensors for extreme conditions of fusion energy environments Thirteen ...

By Dr. Priyom Bose, Ph.D. New research reveals how plant-based flavonoids can regulate gut hormones like GLP-1 and ghrelin, ...

InflaRx (NASDAQ:IFRX – Free Report) had its target price hoisted by Guggenheim from $7.00 to $10.00 in a report published on Wednesday morning, Ratings reports. The brokerage currently has a buy ...

NEW HAVEN, Conn., March 27, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in ...

Indian Institute of Technology Madras (IIT Madras) has launched ‘Zero e-mission’, a comprehensive set of e-Mobility ...

Over the past decades, roboticists have introduced a wide range of systems that can move in various complex environments, ...

Updated data confirms statistically significant 32% higher ORR and 3.5 month longer PFS in second-line CRC patients with high DKK1 levels treated with sirexatamab plus ...